CALGARY, AB, May 13, 2022 /CNW/ - Universal Ibogaine Inc. (TSXV:IBO.VN) (OTC-BB:IBOGF) (FSE:JC4) ("UI" or the "Company") a life sciences company with a mission to transform addiction treatment through the use of medicalized ibogaine and a global licensing model is pleased to announce that UI Co-Founder Dr Alberto Sola will present at the May 27 to 29 event: From Research to Reality: Global Summit on Psychedelic Assisted Therapies and Medicine which will be held in Toronto, Canada from May 27 to 29, 2022.
Read more at newswire.caUniversal Ibogaine Co-Founder Dr Alberto Sola to Present at upcoming Research to Reality Conference
Newswire.ca - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here